CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)
Product revenue	$ 334.6	$ 362.2	$ 968.8	$ 1,127.2
Service revenue	58.8	56.0	171.1	170.7
Other revenue	2.7	1.6	5.7	3.0
Total revenue	396.1	419.8	1,145.6	1,300.9
Cost of product revenue	193.1	214.6	545.8	638.9
Cost of service revenue	34.8	37.9	101.7	114.5
Cost of other revenue	0.7		1.0
Total cost of revenue	228.6	252.5	648.5	753.4
Gross profit	167.5	167.3	497.1	547.5
Operating expenses:
Selling, general and administrative	96.1	108.0	289.2	332.5
Research and development	34.3	42.1	109.0	132.6
Other charges, net	8.9	12.3	23.9	21.5
Total operating expenses	139.3	162.4	422.1	486.6
Operating income	28.2	4.9	75.0	60.9
Interest and other income (expense), net	(4.6)	4.1	(14.3)	(3.1)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	23.6	9.0	60.7	57.8
Income tax provision	10.7	2.7	17.8	24.7
Consolidated net income	12.9	6.3	42.9	33.1
Net income attributable to noncontrolling interest in consolidated subsidiaries	1.1	0.8	2.7	2.5
Net income attributable to Bruker Corporation	$ 11.8	$ 5.5	$ 40.2	$ 30.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic and diluted (in dollars per share)	$ 0.07	$ 0.03	$ 0.24	$ 0.18
Weighted average common shares outstanding:
Basic (in shares)	167.8	168.0	168.2	167.5
Diluted (in shares)	168.7	169.6	169.1	169.5
Comprehensive income (loss)	$ 5.0	$ (76.7)	$ 6.7	$ (50.3)
Less: Comprehensive income attributable to noncontrolling interests	1.2	0.8	2.4	2.5
Comprehensive income (loss) attributable to Bruker Corporation	$ 3.8	$ (77.5)	$ 4.3	$ (52.8)